Abstract B62: Potent single agent in vivo activity of the PARP inhibitor veliparib (ABT-888) in BRCA-deficient xenografts (MX-1 and Capan-1).
Cherrie K Donawho,Luis E Rodriguez,Paul A Ellis, L Kaleta,Gail Bukofzer,Velitchka Bontchevadiaz, Xinjuan Liu,Jennifer J Bouska, Richard V C Carr,Kenneth B Idler,Joann P Palma,David J Frost,Fritz G Buchanan,Vincent L Giranda,Alexander R Shoemaker,Thomas D Penning,Guangshan Zhu Molecular Cancer Therapeutics（2011）
AI 理解论文
溯源树
样例
